상업 바이오테크놀러지용 분리 시스템 시장 규모, 점유율, 동향 분석 보고서 : 방법별, 용도별, 지역별, 부문별 예측(2024-2030년)

Separation Systems For Commercial Biotechnology Market Growth & Trends:

The global separation system for commercial biotechnology market size is expected to reach USD 40.55 billion by 2030, expanding at a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.

Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for the production of food & cosmetics, agriculture, plastics, and chemicals.

Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand for potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.

Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.

Separation Systems For Commercial Biotechnology Market Report Highlights:

• Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment.
• However, modern methods are anticipated to grow at the fastest pace in the coming years due to the rise in adoption of these technologies.
• Technological advancements in product capabilities are anticipated to boost the separation systems for commercial biotechnology market.
• Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics.
• Rising prevalence of various chronic disorders is indirectly boosting growth.
• North America dominated the market with adequate administrative support, extensive research, and well-established industrial framework.
• Asia Pacific region is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support.
• Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systems.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Separation Systems for Commercial Biotechnology Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Separation Systems for Commercial Biotechnology Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Separation Systems for Commercial Biotechnology Market: Method Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Separation Systems for Commercial Biotechnology Market: Method Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Conventional Methods
  • 4.3.1. Conventional Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Chromatography
    • 4.3.2.1. Chromatography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Flow Cytometry
    • 4.3.3.1. Flow Cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.4. Membrane Filtration
    • 4.3.4.1. Membrane Filtration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.5. Electrophoresis
    • 4.3.5.1. Electrophoresis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.6. Centrifugation
    • 4.3.6.1. Centrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Modern Methods
  • 4.4.1. Modern Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Microarray
    • 4.4.2.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Lab-on-a-chip
    • 4.4.3.1. Lab-on-a-chip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Magnetic Separation
    • 4.4.4.1. Magnetic Separation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Biochip
    • 4.4.5.1. Biochip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Separation Systems for Commercial Biotechnology Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Separation Systems for Commercial Biotechnology Market: Application Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Pharmaceutical
  • 5.3.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Vaccines
    • 5.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Proteins
    • 5.3.3.1. Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. Hormones/Insulin
    • 5.3.4.1. Hormones/Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.5. Enzymes
    • 5.3.5.1. Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.6. Human Blood Plasma Fractionation
    • 5.3.6.1. Human Blood Plasma Fractionation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.7. Mammalian Cell Cultures
    • 5.3.7.1. Mammalian Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Food & Cosmetics
  • 5.4.1. Food & Cosmetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Agriculture
  • 5.5.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Separation Systems for Commercial Biotechnology Market: Regional Estimates & Trend Analysis

• 6.1. Separation Systems for Commercial Biotechnology Market Share, By Region, 2023 & 2030 (USD Million)
• 6.2. North America
  • 6.2.1. North America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Canada Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Germany Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. France Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Italy Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Spain Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Denmark Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Sweden Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Norway Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Japan Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. China Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. India Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Australia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. South Korea
    • 6.4.6.1. South Korea Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1. Thailand Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Argentina Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Saudi Arabia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. UAE Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Kuwait Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Thermo Fisher Scientific Inc.
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/Strategic Initiatives
  • 7.4.2. QIAGEN
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/Strategic Initiatives
  • 7.4.3. Horizon Discovery Ltd.
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/Strategic Initiatives
  • 7.4.4. OriGene Technologies, Inc.
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/Strategic Initiatives
  • 7.4.5. Oxford Biomedica PLC
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/Strategic Initiatives
  • 7.4.6. SignaGen Laboratories
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/Strategic Initiatives
  • 7.4.7. Flash Therapeutics
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/Strategic Initiatives
  • 7.4.8. Takara Bio Inc.
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/Strategic Initiatives
  • 7.4.9. Bio-Rad Laboratories, Inc.
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/Strategic Initiatives
  • 7.4.10. System Biosciences, LLC.
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Recent Developments/Strategic Initiatives
  • 7.4.11. Promega Corporation
    • 7.4.11.1. Participant's Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Recent Developments/Strategic Initiatives
  • 7.4.12. F. Hoffmann-La Roche Ltd
    • 7.4.12.1. Participant's Overview
    • 7.4.12.2. Financial Performance
    • 7.4.12.3. Product Benchmarking
    • 7.4.12.4. Recent Developments/Strategic Initiatives
  • 7.4.13. Revvity
    • 7.4.13.1. Participant's Overview
    • 7.4.13.2. Financial Performance
    • 7.4.13.3. Product Benchmarking
    • 7.4.13.4. Recent Developments/Strategic Initiatives
  • 7.4.14. Catalent, Inc
    • 7.4.14.1. Participant's Overview
    • 7.4.14.2. Financial Performance
    • 7.4.14.3. Product Benchmarking
    • 7.4.14.4. Recent Developments/Strategic Initiatives